We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

165 hedge funds and large institutions have $1.75B invested in Arena Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 51 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 51

15% more capital invested

Capital invested by funds: $1.53B → $1.75B (+$225M)

3% less funds holding

Funds holding: 170 → 165 (-5)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

18% less call options, than puts

Call options by funds: $34.8M | Put options by funds: $42.5M

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
165
Holders Change
-5
Holders Change %
-2.94%
% of All Funds
3.78%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
22
Increased
69
Reduced
51
Closed
25
Calls
$34.8M
Puts
$42.5M
Net Calls
-$7.78M
Net Calls Change
-$47.4M

Top Buyers

1
PHS
PFM Health Sciences
California
+$51.4M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$44.3M
3
PA
Perceptive Advisors
New York
+$28.8M
4
BlackRock
BlackRock
New York
+$22.8M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$22.7M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$43.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$38.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$34.2M
4
Millennium Management
Millennium Management
New York
-$13.5M
5
DM
Deerfield Management
New York
-$12.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
FMBTD
176
First Midwest Bank Trust Division
Illinois
– -$558K -14,138 Closed
GCP
177
GSA Capital Partners
United Kingdom
– -$480K -12,154 Closed
MA
178
MYDA Advisors
New York
– -$474K -12,000 Closed
Arrowstreet Capital
179
Arrowstreet Capital
Massachusetts
– -$437K -11,057 Closed
MS
180
Maven Securities
Jersey
– -$247K -6,245 Closed
OAM
181
Oxford Asset Management
United Kingdom
– -$239K -6,042 Closed
GAM
182
Gotham Asset Management
New York
– -$214K -5,406 Closed
BFM
183
Boothbay Fund Management
New York
– -$201K -5,093 Closed
APP
184
Avantax Planning Partners
Iowa
– -$40K -1,000 Closed
FANJ
185
Financial Architects (New Jersey)
New Jersey
– -$20K -500 Closed
TRCT
186
Tower Research Capital (TRC)
New York
– -$13K -323 Closed
Carson Wealth (CWM LLC)
187
Carson Wealth (CWM LLC)
Nebraska
– -$6K -150 Closed
GWM
188
Geneos Wealth Management
Colorado
– -$3K -100 Closed
CCA
189
Clearwater Capital Advisors
Illinois
– -$2K -50 Closed
4 5 6 7
8

ARNA Hedge Fund Activity: Q2 2018 in Review

165 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2018, worth a combined $1.75B — up 15% from $1.53B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ARNA and 22 opened new positions — a net loss of 3 holders — while 51 trimmed existing stakes and 69 added.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $51.4M. The largest seller was Great Point Partners, cutting an estimated $43.1M.

  • 165 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2018, down from 170 in Q1 2018.
  • Funds reported $1.75B of Arena Pharmaceuticals Inc stock for Q2 2018, up 15% quarter-over-quarter.
  • 22 funds opened new Arena Pharmaceuticals Inc positions in Q2 2018 and 25 closed out, a net change of -3 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2018 was PFM Health Sciences, an estimated $51.4M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2018 was Great Point Partners, an estimated $43.1M sold.

Based on aggregated 13F filings for Q2 2018.